PHILADELPHIA, June 2, 2004 – LAWFUEL – GlaxoSmithKline has acted responsibly in conducting clinical studies in pediatric patients and disseminating data from those studies.
All pediatric studies have been made available to the FDA and regulatory
agencies worldwide. We have publicly communicated data from all pediatric
As for the 1998 memo, it is inconsistent with the facts and does not
reflect the company position.
GlaxoSmithKline (NYSE: GSK) is one of the world’s leading pharmaceutical
and healthcare companies and is committed to improving the quality of human
life by enabling people to do more, feel better and live longer. For more
information on the Orange Card, or general company information, visit
GlaxoSmithKline on the World Wide Web at http://www.gsk.com.